| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/27/2001 | EP1110953A1 Quinazoline derivatives |
| 06/27/2001 | EP1110945A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 06/27/2001 | EP1109807A1 Benzoyl derivatives, method for producing them and their use as herbicides and plant growth regulators |
| 06/27/2001 | EP1109800A1 Novel cdk inhibitors having flavone structure |
| 06/27/2001 | EP1109544A1 Potassium channel inhibitors and method |
| 06/27/2001 | EP0824518B1 (het)aryloxy-, -thio-, aminocrotonates, methods of preparing them and their use as insecticides and fungicides |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301264A Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 06/27/2001 | CN1301258A Benzofuroxan derivatives and their use in treating angina pectoris |
| 06/27/2001 | CN1301255A Heterocyclically substituted amides, their production and their use |
| 06/27/2001 | CN1301253A Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 06/27/2001 | CN1301154A Amide derivatives and nociceptin antagonists |
| 06/27/2001 | CN1067683C Substituted morpholine derivatives and their use as therapeutic agents |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/26/2001 | US6252094 Using onium salt in aqueous solvent |
| 06/26/2001 | US6252086 4-alkenyl-and 4-alkynyloxindoles |
| 06/26/2001 | US6252085 Oxazoline derivative |
| 06/26/2001 | US6252080 Herpes, cytomegalo virus |
| 06/26/2001 | US6251926 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 06/26/2001 | US6251923 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation |
| 06/26/2001 | US6251921 Administering thrombin inhibiting diamine compound to mammal |
| 06/26/2001 | US6251907 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics |
| 06/26/2001 | US6251900 Heterocyclic compounds and antitumor agent containing the same as active ingredient |
| 06/26/2001 | US6251899 Microbioicides |
| 06/26/2001 | US6251897 6-phenyltetrahydro-1,3-oxazin-2-one derivative and pharmaceutical composition containing the same |
| 06/26/2001 | US6251894 1-(1,2-disubstituted piperidinyl)-4 (fused imidazole)-piperidine derivatives |
| 06/26/2001 | US6251869 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives |
| 06/24/2001 | CA2329516A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 06/21/2001 | WO2001044324A2 Polymerization of olefins |
| 06/21/2001 | WO2001044239A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | WO2001044238A1 Pyrazolyl benzyl ethers |
| 06/21/2001 | WO2001044229A1 Chemokine receptor binding heterocyclic compounds |
| 06/21/2001 | WO2001044223A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | WO2001044214A1 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient |
| 06/21/2001 | WO2001044213A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | WO2001044211A1 Novel 3-oxo-2,1-benzisoxazol-1(3h)-carboxamides for treatment of cns diseases |
| 06/21/2001 | WO2001044208A1 4,6-substituted 2-amino-1,3,5-triazine derivatives, a method for producing same and the use thereof as herbicides and plant growth regulators |
| 06/21/2001 | WO2001044201A1 Substituted imidazole neuropeptide y y5 receptor antagonists |
| 06/21/2001 | WO2001044200A2 Selective neurokinin antagonists |
| 06/21/2001 | WO2001044195A1 Heterocycle derivatives and drugs |
| 06/21/2001 | WO2001044189A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 06/21/2001 | WO2001044188A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 06/21/2001 | WO2001044179A1 Novel succinate compounds, compositions and methods of use and preparation |
| 06/21/2001 | WO2001044178A1 Novel urea compounds, compositions and methods of use and preparation |
| 06/21/2001 | DE19960917A1 Neue 3-Oxo-2,1-benzisoxazol-1(3H)-carboxamide zur Behandlung von ZNS-Erkrankungen New 3-oxo-2,1-benzisoxazol-1 (3H) -carboxamide for the treatment of CNS disorders |
| 06/21/2001 | CA2395167A1 Novel 3-oxo-2,1-benzisoxazol-1(3h)-carboxamides for treatment of cns diseases |
| 06/21/2001 | CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | CA2393825A1 Novel succinate compounds, compositions and methods of use and preparation |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/21/2001 | CA2393358A1 Heterocycle derivatives and drugs |
| 06/21/2001 | CA2393027A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | CA2392894A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/20/2001 | EP1108713A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 06/20/2001 | EP1108712A1 3-Hydroxy-4,5-bis(morpholin-1-yl)pyridazine as UV absorber |
| 06/20/2001 | EP1107964A1 Isoquinoline derivatives with angiogenesis inhibiting activity |
| 06/20/2001 | EP1107954A1 2-OXO-$i(2H)-QUINOLINE DERIVATIVES |
| 06/20/2001 | EP1107756A1 Novel isoxazolinone antibacterial agents |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP0984961B1 Novel pyridine derivatives and pharmaceutical compositions containing them |
| 06/20/2001 | EP0808303B1 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist |
| 06/20/2001 | EP0757682B1 Benzofuran derivatives useful as inhibitors of bone resorption |
| 06/20/2001 | CN1300288A Water soluble azoles as broad-spectrum antifungals |
| 06/20/2001 | CN1300287A Water soluble azoles as broad-spectrum antifungals |
| 06/20/2001 | CN1300285A Oxyiminoalkanoic acid derivatives |
| 06/20/2001 | CN1300284A Method for producing isoxazoline-3-yl-acyl benzene |
| 06/20/2001 | CN1299819A (R)-2[3-(2-N-phthalic amido ethyl)-4,5-dihydro-5-isoxazolyl]-acetic acid and its synthesis |
| 06/20/2001 | CN1067391C Piperidyl methyl oxazolidinone |
| 06/20/2001 | CN1067384C Adhesion receptor antagonists, its preparation method and use as farm chemicals |
| 06/20/2001 | CN1067379C Process of 5-(substituted methyl)-2,3-pyridinedicarboxylic acids |
| 06/19/2001 | US6248897 From beta-methyl l-aspartate |
| 06/19/2001 | US6248895 Benzofuroxan compound, method of preparation, pharmaceutical composition and method of treatment using the same |
| 06/19/2001 | US6248767 Formulation of sulfonamides for treatment of endothelin-mediated disorders |
| 06/19/2001 | US6248765 Imidazole derivatives as histamine receptor H3 (ANT) agonists |
| 06/19/2001 | US6248757 Antiserotonine agents |
| 06/19/2001 | US6248756 Inhibitors of farnesyl-protein transferase |
| 06/19/2001 | US6248755 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 06/19/2001 | US6248754 Psychological disorders |
| 06/19/2001 | US6248747 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
| 06/19/2001 | US6248739 Quinolinecarboxamides as antiviral agents |
| 06/19/2001 | CA2095444C Fused pyrazine derivatives |
| 06/19/2001 | CA2029838C Process for the preparation of aminotriazine derivatives |
| 06/14/2001 | WO2001042243A2 Protein kinase inhibitors |
| 06/14/2001 | WO2001042242A1 Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 06/14/2001 | WO2001042241A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | WO2001042229A1 Antibacterial amidinomethyl- and guanidinomethyl-oxazolidinones |
| 06/14/2001 | WO2001042227A1 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof |
| 06/14/2001 | WO2001042213A1 Urea compounds having muscarinic receptor antagonist activity |
| 06/14/2001 | WO2001042212A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 06/14/2001 | WO2001042208A1 Cycloamine ccr5 receptor antagonists |
| 06/14/2001 | WO2001042179A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/14/2001 | WO2001028537A3 Bissulfonamide derivatives as enzyme inhibitors |
| 06/14/2001 | WO2001002373A8 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 06/14/2001 | US20010003747 Useful in treating or in preventing melatoninergic disorders |
| 06/14/2001 | CA2393968A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/14/2001 | CA2392584A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/13/2001 | EP1106608A1 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/13/2001 | EP1106606A2 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 06/13/2001 | EP1106605A1 Alpha1b-adrenergic receptor antagonists |
| 06/13/2001 | EP1106210A2 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
| 06/13/2001 | EP1105383A2 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |